Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Applauds ANVISA’s New Regulations of Medical Cannabis Products in Brazil

by Kim Nunley | Dec 5, 2019 | HempMeds Brasil, Press Releases

SAN DIEGO, Dec. 5, 2019 /PRNewswire/ — Medical Marijuana, Inc. (“the Company”) (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products,...

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Vice President Invited to Speak on Key Panel at 2019 Marijuana Business Conference

by Jeffrey Stamberger | Nov 19, 2019 | HempMeds Brasil, Press Releases

SAN DIEGO, Nov. 19, 2019 — Medical Marijuana, Inc. (“the Company”) (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply...

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Vice President Hosts Panel at Lide Futuro Debate in São Paulo

by Jeffrey Stamberger | Oct 15, 2019 | HempMeds Brasil, Press Releases

SAN DIEGO, Oct. 15, 2019 — Medical Marijuana, Inc. (“the Company”) (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply...

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Signs Agreement with Online Marketplace Dr. Cannabis

by Jeffrey Stamberger | Sep 17, 2019 | HempMeds Brasil, Press Releases

SAN DIEGO, Sept. 17, 2019 — Medical Marijuana, Inc. (“the Company”) (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and...

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hires Gabriel Barbosa as Scientific Projects and Regulatory Developing Analyst

by Jeffrey Stamberger | Sep 5, 2019 | HempMeds Brasil, Press Releases

SAN DIEGO, Sept. 5, 2019 — Medical Marijuana, Inc. (“the Company”) (OTC:MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply...

Medical Marijuana, Inc. Subsidiaries HempMeds®, HempMeds® Mexico and HempMeds® Brasil Announce July 2019 as the Largest Sales Bookings Month in Company History

by Jeffrey Stamberger | Aug 6, 2019 | HempMeds, HempMeds Brasil, HempMeds Mexico, Press Releases

SAN DIEGO, Aug. 6, 2019 — Medical Marijuana, Inc. (OTC:MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply...